Malaka Ameratunga

Loop profile Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Interstitial Lung Disease

Brain Metastases

Top Venues

Journal of clinical pharmacy and therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Experimental dermatology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Knox, Tim Wang, Mark Shackleton, Malaka Ameratunga
Symptomatic brain metastases in melanoma. Experimental dermatology 33 (4) (2024)
Farzana Yasmin Zaman, Catriona McLean, Malaka Ameratunga
Dramatic clinical response in the treatment of small cell glioblastoma multiforme. Journal of clinical pharmacy and therapeutics 47 (6) (2022)
Albert A Antolin, Malaka Ameratunga, Udai Banerji, Paul Andrew Clarke, Paul Workman, Bissan Al-Lazikani
The kinase polypharmacology landscape of clinical PARP inhibitors. Scientific reports 10 (1) (2020)
Wing Hing Yau, Malaka Ameratunga
Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma. Journal of clinical pharmacy and therapeutics 45 (5) (2020)
Angelika Terbuch, Crescens Tiu, Irene Moreno Candilejo, Mariana Scaranti, Andra Curcean, Dan Bar, Miriam Estevez Timon, Malaka Ameratunga, Joo Ern Ang, Jonathan Ratoff, Anna R Minchom, Udai Banerji, Johann S de Bono, Nina Tunariu, Juanita S Lopez
Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Malaka Ameratunga, Emma Kipps, Alicia F C Okines, Juanita S Lopez
To Cycle or Fight-CDK4/6 Inhibitors at the Crossroads of Anticancer Immunity. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)